How different ligands affect oxygen activation in biocatalysts
Contribution of Ligand Sets to Oxygen Activation in Iron-dependent Biocatalysts
This study looks at how different molecules help iron-based enzymes activate oxygen, which is important for life, to better understand how these enzymes work and how they can be used to improve biological processes.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Georgia NIH-funded |
| Lab location | 1 site (Athens, United States) |
| Project ID | NIH-11092228 on NIH RePORTER |
What this research studies
This research investigates how various ligand sets influence the activation of oxygen in iron-dependent biocatalysts, which are essential for aerobic life. By studying metalloenzymes, particularly heme and non-heme iron enzymes, the project aims to understand the mechanisms behind oxygen activation and its role in manipulating biomolecules. The research will systematically compare these systems to uncover why certain ligands are preferred for specific reactions, potentially leading to advancements in biocatalysis and metabolic processes.
Who could benefit from this research
Good fit: Ideal candidates for this research would include individuals with conditions related to impaired aerobic metabolism or those affected by diseases where biocatalysis plays a role.
Not a fit: Patients with conditions unrelated to aerobic metabolism or biocatalytic processes may not receive any benefit from this research.
Why it matters
Potential benefit: If successful, this research could enhance our understanding of biocatalysis, leading to improved methods for manipulating biological processes and developing new therapeutic strategies.
How similar studies have performed: While the specific approach of comparing ligand sets in iron-dependent biocatalysts is novel, similar studies in enzyme catalysis have shown promising results in understanding metabolic processes.
Where this research is happening
Athens, United States
- University of Georgia — Athens, United States (Active)
Researchers
- Principal investigator: Wang, Yifan — University of Georgia
- Study coordinator: Wang, Yifan
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.